Hay que añadir un cuarto fármaco a la pauta actual de tratamiento de la tuberculosis inicial?

N. M. Casabona; J. A. Caylà

doi:10.1016/s0025-7753(01)71931-8

Hay que añadir un cuarto fármaco a la pauta actual de tratamiento de la tuberculosis inicial?

Translated title of the contribution: Is it necessary to add a fourth drug to the initial treatment of tuberculosis?

N. M. Casabona, J. A. Caylà

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

Translated title of the contribution	Is it necessary to add a fourth drug to the initial treatment of tuberculosis?
Original language	Spanish
Number of pages	1
Journal	Medicina clínica
Volume	116
Issue number	16
DOIs	https://doi.org/10.1016/s0025-7753(01)71931-8
State	Published - May 5 2001

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/s0025-7753(01)71931-8

Cite this

@article{e951b1b0451742ecba8e129804340e7c,

title = "Hay que a{\~n}adir un cuarto f{\'a}rmaco a la pauta actual de tratamiento de la tuberculosis inicial?",

author = "Casabona, {N. M.} and Cayl{\`a}, {J. A.}",

year = "2001",

month = may,

day = "5",

doi = "10.1016/s0025-7753(01)71931-8",

language = "Spanish",

volume = "116",

journal = "Medicina Clinica",

issn = "0025-7753",